Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methods
These findings provide rationale for clinical testing of pBI-11 DNA vaccine delivered by electroporation for the control of HPV16/18-associated infections and/or cancers.
Authors
- Chien‐Fu Hung (ORCID: https://orcid.org/0000-0001-9170-7797)
- T.‐C. Wu (ORCID: https://orcid.org/0000-0003-1623-4584)
- Shiwen Peng (ORCID: https://orcid.org/0009-0003-0886-0734)
- Rebecca C. Arend (ORCID: https://orcid.org/0000-0003-2108-3426)
- Hsin-Fang Tu (ORCID: https://orcid.org/0009-0008-9048-493X)
- Richard B.S. Roden (ORCID: https://orcid.org/0000-0002-2506-0195)
- Michelle Y. Cheng (ORCID: https://orcid.org/0009-0009-3158-8226)
- Julia Tao (ORCID: https://orcid.org/0009-0005-3702-8327)
- Darrell Fan
- Kimberly Levinson (ORCID: https://orcid.org/0000-0002-6457-9635)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Cell & Bioscience
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1186/s13578-024-01338-x
- Citations
- 2
- Primary Topic
- Microbial infections and disease research
- Type
- article
- Field-Weighted Citation Impact
- 0.69
Funders
- National Cancer Institute